Related references
Note: Only part of the references are listed.Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
Imre Noth et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis
Ganesh Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis
Luca Richeldi et al.
THORAX (2012)
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis Test Properties and Minimal Clinically Important Difference
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium
Steven D. Nathan et al.
CHEST (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Treatment of pulmonary arterial hypertension with targeted therapies
Dermot S. O'Callaghan et al.
NATURE REVIEWS CARDIOLOGY (2011)
The rising incidence of idiopathic pulmonary fibrosis in the UK
V. Navaratnam et al.
THORAX (2011)
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
C. J. Zappala et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Pirfenidone in idiopathic pulmonary fibrosis
H. Taniguchi et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
C. Vancheri et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Strategies for treating idiopathic pulmonary fibrosis
R. M. du Bois
NATURE REVIEWS DRUG DISCOVERY (2010)
A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
David A. Zisman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
Talmadge E. King et al.
LANCET (2009)
Idiopathic pulmonary fibrosis
Eric B. Meltzer et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
A Azuma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Share Paper
